4//SEC Filing
Asterias Biotherapeutics, Inc. 4
Accession 0001140361-17-001017
CIK 0001572552operating
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 5:13 PM ET
Size
8.0 KB
Accession
0001140361-17-001017
Insider Transaction Report
Form 4
Wirth Edward
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2016-12-27$2.34/sh+2,500$5,850→ 2,500 total - Sale
Common Stock
2016-12-27$5.00/sh−2,500$12,500→ 0 total - Exercise/Conversion
Options to Purchase Common Stock
2016-12-27+2,500→ 192,500 totalExercise: $2.34From: 2013-03-10Exp: 2020-03-09→ Common Stock (2,500 underlying)
Footnotes (2)
- [F1]The shares reported herein were sold pursuant to a Rule 10b5-1 Plan adopted by the reporting person.
- [F2]Excludes 5,471 Restricted Stock Units payable in shares of the Issuer's common stock that have not vested as of the date of this Report.
Documents
Issuer
Asterias Biotherapeutics, Inc.
CIK 0001572552
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001572552
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 5:13 PM ET
- Size
- 8.0 KB